A Phase 3, 52-week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis (PN) Who are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies

Project: Research

Project Details

StatusActive
Effective start/end date30/07/24 → 29/07/26

Keywords

  • Clinical Trials
  • 20230053